AI in Drug Discovery Market to Grow at 29.89% CAGR from 2025 to 2032

The Artificial Intelligence in Drug Discovery Market is experiencing rapid growth, driven by increasing demand for faster, more cost-effective drug development solutions. Valued at USD 1.92 billion in 2024, the market is projected to reach USD 15.50 billion by 2032, expanding at a robust CAGR of 29.89% from 2025 to 2032. Artificial Intelligence (AI) is transforming the pharmaceutical and biotechnology sectors by streamlining traditional drug discovery processes that are typically time-consuming, costly, and resource-intensive. Leveraging advanced technologies such as machine learning (ML), deep learning, natural language processing (NLP), and predictive analytics, AI is accelerating various stages of drug development — from target identification and compound screening to preclinical testing and clinical trial design.